Clinical Trial

Development of Novel Physiological CMR Methods in Health and Disease

Recruiting
View on ClinicalTrials.gov →
Summary
Physiological cardiovascular stress test plays a crucial role in the assessment of patients with suspected heart disease. There are several methods of cardiac physiological stress tests and each of them offer varied insight into cardiac physiological adaptation: passive leg raise, intra-venous fluid challenge, pharmacological stressors and physical exercise stress test. Echocardiography, which is the mainstay for the non-invasive rest/stress assessment of the left ventricular (LV) haemodynamics has several limitations. Novel methods of CMR imaging allow to map intra-cardiac flow in three-dimension using novel flow acquisitions. These novel flow acquisitions are called four-dimensional flow CMR, where the fourth dimension is time. Additionally, traditional cine CMR imaging for functional assessment can now be done without breath-holds using advanced acceleration methods, allowing them to be used during exercise. A comprehensive understanding of functional-flow coupling at rest, during increased pre-load (fluid challenge) to the heart or during exercise, is lacking in the literature. There is an important need to validate these novel CMR methods for developing mechanistic insight into physiological cardiac adaptation to increased pre-load or to exercise in health and how it alters in heart disease.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-02-25; most recent amendment 2026-03-16.
Status change: Suspended → Recruiting 2024-12-09
Status change: Recruiting → Suspended 2023-11-09
Status change: Suspended → Recruiting 2020-03-17
Trial Details
NCT Number NCT03854071
Lead Sponsor Sheffield Teaching Hospitals NHS Foundation Trust
Conditions Heart Failure, Pulmonary Hypertension, Myocardial Infarction, Coronary Artery Disease
Enrollment 135 participants
Start Date 2018-07-30
Primary Completion 2030-01-01 (estimated)
Study Completion 2031-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-18